Clinical and Economic Impact of a Multidisciplinary Follow-Up Program in Lymphoma Patients.

Madeline DevauxMathieu BoulinMorgane MounierDenis CaillotNuri AhwijAdélie HerbinJean Noël BastieCamille FavennecPhilippine RobertPauline PistreStephanie BostPauline AmiotLaurence JacquessonRené-Olivier Casasnovas Cédric RossiPauline Gueneau

Published in: Cancers (2022)

A nurse-pharmacist-haematologist collaboration seems to be promising to reduce grade 3-4 AEs in HL and NHL patients receiving highly haematotoxic chemotherapy regimens. Cost savings from hospitalisation being avoided were also shown.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
quality improvement
primary care
prognostic factors
peritoneal dialysis
diffuse large b cell lymphoma
locally advanced
patient reported outcomes
radiation therapy
rectal cancer